Summary of Purpose
This study evaluates the safety and efficacy of an analog-sedation protocol for patients with mild to moderate brain injuries in intensive care unit. Patients are randomly divided into two groups. The Analgesia-based sedation group will receive remifentanil before the addition of a sedative(Dexmedetomidine). The conventional-based sedation group will be sedated as usual(non-protocolized). Furthermore，patients in...Read More →
The following dates are available for this trial. Trial information last updated on 22 July 2017.
|1 Aug 2017||26 Jun 2017||1 Aug 2021||1 Aug 2021||1 Jul 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|